Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,997 | -18,399 | -9,236 | -31,180 | -23,134 |
| Depreciation Amortization | 814 | 517 | 256 | 891 | 635 |
| Accounts payable and accrued liabilities | 3,489 | 16 | -129 | 843 | 2 |
| Other Working Capital | -5,327 | 1,175 | 808 | 104 | 1,609 |
| Other Operating Activity | 3,412 | 3,588 | 2,234 | 3,524 | 3,132 |
| Operating Cash Flow | $-21,609 | $-13,103 | $-6,067 | $-25,818 | $-17,756 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,344 | -297 | -93 | -1,386 | -1,280 |
| Other Investing Activity | -16,387 | 0 | 0 | 1,245 | 1,494 |
| Investing Cash Flow | $-17,731 | $-297 | $-93 | $-141 | $214 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 97 | N/A | N/A | N/A | 0 |
| Debt Repayment | -23 | -18 | -9 | -66 | -56 |
| Common Stock Issued | 29,382 | 29,247 | 28,811 | 67,215 | 49,423 |
| Common Stock Repurchased | -222 | -182 | -182 | N/A | 0 |
| Other Financing Activity | -115 | -77 | -38 | -149 | -111 |
| Financing Cash Flow | $29,119 | $28,970 | $28,582 | $67,000 | $49,256 |
| Beginning Cash Position | 61,291 | 61,291 | 61,291 | 20,250 | 20,250 |
| End Cash Position | 51,070 | 76,861 | 83,713 | 61,291 | 51,964 |
| Net Cash Flow | $-10,221 | $15,570 | $22,422 | $41,041 | $31,714 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,609 | -13,103 | -6,067 | -25,818 | -17,756 |
| Capital Expenditure | -1,344 | -297 | -93 | -1,386 | -1,280 |
| Free Cash Flow | -22,953 | -13,400 | -6,160 | -27,204 | -19,036 |